KCRS23 Leadership Committee

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Director, Barts Cancer Centre

BRYAN LEWIS

KidneyCAN
President

SUSAN POTEAT

KidneyCAN
Medical Science Liaison

Abstract Committee

STEVEN CHANG, MD, MS

Brigham and Women’s Hospital
Associate Surgeon

DEEPAK KILARI, MD

Medical College of Wisconsin
Associate Professor

JOSHUA LANG, MD, MS

University of Wisconsin School of Medicine
Associate Professor

CHUNG-HAN LEE, MD, PhD

Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

BRIAN SHUCH, MD

University of California, Los Angeles
Associate Professor of Urology

WENXIN (Vincent) XU, MD

Dana-Farber Cancer Institute
Instructor of Medicine

DoD / KCRP Session Committee

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center
Associate Professor

ERIC JONASCH, MD

MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology

SRINIVAS VISWANATHAN, MD, PhD

Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School

QING ZHANG, PhD

UT Southwestern
Associate Professor

Communications Committee

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

NAZLI DIZMAN, MD

MD Anderson Cancer Center
Internal Medicine Resident

GIL MORGAN, MD

Skane University Hospital
Medical Oncologist

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Institute
Assistant Professor, Department of Genitourinary Medical Oncology

FABIO SCHUTZ, MD

BP – A Beneficencia, Portuguesa de Sao Paulo
Oncologista Clinico

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute
Medical Oncologist

QING ZHANG, PhD

UT Southwestern
Associate Professor

TIAN ZHANG, MD

UT Southwestern
Associate Professor

ADRIAN HAYES

KidneyCAN
Communications

Mentorship: Challenges and Opportunities

MODERATORS

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Lead for Solid Tumour Research

panelists

LAURENCE ALBIGES, MD, PhD

Institute Gustave-Roussy
Urology Committee Chairman

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

NAZLI DIZMAN, MD

Yale School of Medicine
Internal Medicine Resident

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

RENEE MARIA SALIBY, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

session 1

Modulating Tumor Microenvironment in Kidney Cancer

MODERATORS

ERIC JONASCH, MD

MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center
Associate Professor

speakers

RUHEE DERE, PhD

Baylor College of Medicine
Assistant Professor

ELEONORA DONDOSSOLA, PhD

MD Anderson Cancer Center
Assistant Professor

HARTLAND JACKSON, PhD

Samuel Lunenfeld Research Institute
Investigator, Assistant Professor

W. KIMRYN RATHMELL, MD, PhD

Vanderbilt University Medical Center
Director, Division of Hematology & Oncology

session 2

Biology of Non-Clear Cell Subtypes

MODERATORS / SPEAKERS

ELIZABETH HENSKE, MD

Brigham and Women’s Hospital
Professor of Medicine

SRINIVAS VISWANATHAN, MD, PhD

Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School

SPEAKERS

KAUSHAL ASRANI, MBBS, PhD

John Hopkins University
Research Associate

JUNG WOOK PARK, PhD

Duke Cancer Institute
Rollie Assistant Professorship of Correlative Pathology

session 3

Trials in Progress: Moving the Needle

MODERATORS

NAOMI HAAS, MD

Penn Medicine
Clinical Leader of Kidney Cancer Program

ROBERT MOTZER, MD

Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology

SPEAKERS

KATY BECKERMANN, MD, PhD

Vanderbilt University Medical Center
Assistant Professor

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

ERIC JONASCH, MD

MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology

DAVID MCDERMOTT, MD

Beth Israel Deaconess Medical Center
Chief, Division of Medical Oncology

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

NEIL J SHAH, MBBS

Memorial Sloan Kettering Cancer Center
Assistant Attending

special session 4

Breaking Barriers to Trial Enrollment

MODERATOR

MICHAEL B ATKINS, MD

Georgetown Lombardi Comprehensive Cancer Center

panelists

KASEY ESTENSON

Eisai
Medical Director, HCC/GI, RCC, US Medical Affairs

JOSE RICARDO PEREZ, MD

Exelixis
VP, GU Portfolio, Medical Affairs

DANA WALKER

Bristol Myers Squibb
Vice President, Global Progam Lead, Opdivo Genitourinary Cancers and Gastrointestinal Cancers

CARMEN WHITE, MBA

Pfizer
Director of Multicultural Participant Experience

CHANA WEINSTOCK, MD

U.S. Food & Drug Administration (FDA)
GU Oncology Team Leader

FEATURED SPEAKER

WILLIAM G. KAELIN, Jr., MD

Sidney Farber Professor of Medicine, Harvard Medical School
Investigator, Howard Hughes Medical Institute

session 5

Clinical and Scientific Updates in Kidney Cancer

MODERATOR

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

SPEAKERS

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

RAQUIBUL HANNAN, MD, PhD

UT Southwestern Medical Center
Chief of Genitourinary Radiation

CHUNG-HAN LEE, MD, PhD

Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

BRADLEY MCGREGOR, MD

Dana-Farber Cancer Institute
Director of Clinical Research, Lank Center for Genitourinary Oncology

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

ROBERT MOTZER, MD

Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Lead for Solid Tumour Research

session 6

Immunotherapy Advances and Research

MODERATORS

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

SPEAKERS

MARICE ALCANTARA, PhD

City of Hope National Medical Center
Postdoctoral Fellow

MATTHEW DALLOS, MD, PhD

Memorial Sloan Kettering Cancer Center
Assistant Attending

QINQIN JIANG, PhD

Dana-Farber Cancer Institute
Postdoctoral Fellow

AVERY POSEY, PhD

Penn Medicine
Assistant Professor

JOHN WILSON, PhD

Vanderbilt University
Assistant Professor

session 7

Oral Abstract Presentations

MODERATORS

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

JOSHUA LANG, MD, MS

University of Wisconsin School of Medicine
Associate Professor

SPEAKERS

YASSER GED, MBBS

Johns Hopkins University
Assistant Professor of Oncology

CHUNG-HAN LEE, MD, PhD

Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

ANUPAMA REDDY, PhD

Vindhya Data Science Inc.
Co-founder and Data Scientist

ED REZNIK, PhD

Memorial Sloan Kettering Cancer Center
Assistant Member

EDDY SAAD, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

WENXIN (Vincent) XU, MD

Dana-Farber Cancer Institute
Instructor of Medicine

session 8

Rapid Abstract Presentations

MODERATORS

DEEPAK KILARI, MD

Medical College of Wisconsin
Associate Professor

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

SPEAKERS

DANIELA CASTRO, MS

City of Hope Comprehensive Cancer Center
Clinical Research Associate

GEORGE GEBRAEL, MD

Huntsman Cancer Institute
Postdoctoral Research Fellow

CHINMAY JANI, MB, BS

University of Miami, Sylvester Comprehensive Cancer Center
Hematology and Oncology Clinical Fellow

MEI KOH, PhD

Kuda Therapeutics, Inc
CEO

PRATHYUSHA KONDA

Dana-Farber Cancer Institute

CHRIS LABAKI, MD

Dana-Farber Cancer Institute
Medical Oncology Fellow

DAVID SCHOENFELD, MD, PhD

Yale University
Medical Oncology Fellow

KARL SEMAAN, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

Special Session for Investigators:
Expert Insights on the Research Funding Landscape

TAWNYA McKEE, PhD

National Cancer Institute
Program Director

DONALD BOTTARO, PhD

National Cancer Institute
Center for Cancer Research

DARSHAK SANGHAVI, MD

ARPA-H
Program Manager

Pre-meeting: Kidney Cancer Biomarkers Symposium

Session 1: Biomarker Technologies in RCC

moderators

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

MAHRUKH HUSENI

Genentech
Principal Scientist

speakers

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center
Associate Professor

SABINA SIGNORETTI, MD

Brigham and Women’s Hospital
Associate Pathologist

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

TIM SHOWALTER, MD, MPH

Artera
VP of Clinical Development

HEATHER JACENE, MD

Dana-Farber Cancer Institute
Clinical Director, Nuclear Medicine

HEDYEH EBRAHIMI, MD, MPH

City of Hope Comprehensive Cancer C enter
Postdoctoral Fellow

RENEE MARIA SALIBY, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

Session 2: Clinical Biomarkers: Trial Data and Directions

moderators

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Director, Barts Cancer Centre

MEDHI MOLLAPOUR, PhD

State University of New York
Professor

speakers

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Director, Barts Cancer Centre

DAVID McDERMOTT, MD

Beth Israel Deaconess Medical Center
Chief, Division of Medical Oncology

SAURABH GUPTA, PhD

Bristol Myers Squibb
Senior Director, Clinical Biomarkers Oncology, Precision Medicine

AXEL BEX, MD, PhD

Royal Free Hospital London
Clinical Lead of the Specialist Centre for Kidney Cancer

SYLVAN BACA, MD, PhD

Dana-Farber Cancer Institute
Assistant Professor of Medicine

ALEXANDER GUSEV, PhD

Dana-Farber Cancer Institute
Associate Professor

WENXIN (Vincent) XU, MD

Dana-Farber Cancer Institute
Instructor of Medicine

ADAM EINAGGAR, MD

Natera
Medical Director, Oncology